CompoAtlas

Melatonin SAP

Natural health product licensed in Canada

Licence holder
Nutritional Fundamentals for Health Inc.
NPN or DIN-HM
80020684
Status
Active licence
Licence date
12 July 2010
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Mélatonine

Source : Synthétique

3 mgNot calculated

Non-medicinal ingredients

Dioxyde de silicium, Stéarate de magnésium, Dihydrate dibasique de phosphate de calcium, Hypromellose, Acide stéarique, Croscarmellose de sodium

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule, e.g. shift-work and jet lag. Helps relieve the daytime fatigue associated with jet lag. Helps to reduce the time it take to fall asleep (sleep onset latency aspect of sleep quality) in people with delayed sleep phase syndrome. Helps re-set the body's sleep-wake cycle ( aspect of the circadian rhythm).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80020684

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line